Background
Endothelial activation has been proposed as a potential mechanism for the increased risk of venous thromboembolism (VTE) in human immunodeficiency virus (HIV)–infected pregnancy.
Objectives
To assess the state of endothelial activation in HIV‐infected pregnancy by measuring the von Willebrand factor (VWF) propeptide‐to‐antigen ratio, as an index of acute endothelial activation.
Methods
VWF antigen and VWF propeptide were measured in HIV‐negative participants (n = 85), HIV‐infected virologically suppressed participants, (n = 89) and HIV‐infected participants with HIV viral load (VL) of >50 copies/ml (n = 63) in each trimester. Results were correlated with multimer patterns and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS‐13) antigen, activity, and antibody levels.
Results
VWF propeptide‐to‐antigen ratio was increased, in the first, second, and third trimester, in the HIV‐infected virologically suppressed group (1.7 ± 0.7, 1.7 ± 0.4, 1.6 ± 0.5) and the HIV‐infected group with VL > 50 copies/ml (1.9 ± 0.9, 1.7 ± 0.9, 1.6 ± 1.1) compared to the HIV‐negative group (1.4 ± 0.6, 1.3 ± 0.4, 1.2 ± 0.3, P < .05). Increased high molecular weight multimers were observed in the HIV‐infected groups, despite only a mild reduction in ADAMTS‐13 activity compared to the HIV‐negative group (P < .001). No correlation was observed between VWF antigen or VWF propeptide and ADAMTS‐13 activity.
Conclusion
HIV‐infected virologically suppressed pregnant participants showed persistent endothelial activation. Future research should focus on whether endothelial activation contributes to the excess risk of pregnancy‐related VTE.